GlassScriptPhysician profile
Sarah Ann Kidd
NPI 1013367770
$2,744.26
in general payments reported to CMS, 2019-2025
10 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $437 · 2022: $1,326 · 2023: $180 · 2024: $563 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.98 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insightec,INC | $1,862.55 | 2021-2024 | Exablate |
| Medtronic, INC. | $578.04 | 2023-2025 | Percept PC Brainsense, Swiftset, Activa PC |
| Stryker Corporation | $82.83 | 2024 | Everest Spinal System |
| Heron Therapeutics, INC. | $48.03 | 2024 | Zynrelef |
| Abbott Laboratories | $45.11 | 2023 | Infinity, Prodigy |
| Ibsa Pharma INC. | $34.45 | 2023-2024 | Tirosint, Licart, Licart |
| Globus Medical, INC. | $31.53 | 2022 | |
| Bioventus LLC | $23.53 | 2023 | Bonescalpel |
| Kerecis Limited | $20.33 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medinc of Texas | $17.86 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Kidd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.